Posted from: Tuesday, October 07, 2014 - 05:26 PM - Present

Zorvolex Now Approved for Osteoarthritis Pain

August 25, 2014 –The Food and Drug Administration (FDA) extended the approval of Zorvolex to treat the chronic pain associated with osteoarthritis. Zorvolex is manufactured by Iroko Pharmaceuticals.  The brand name version of Zorvolex, diclofenac, was a non-steroidal anti-inflammatory drug (NSAID) approved for the treatment of mild to moderate acute pain.


If you have any questions you can contact our Client Services Call Center at 1-877-723-6005.

Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.


*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.

Last Updated Monday, November 11, 2019 - 11:20 AM.